Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Comera Life Sciences Holdings, Inc. - Common stock (NQ: CMRA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 16, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Comera Life Sciences Holdings, Inc. - Common stock

Comera Life Sciences Announces Process Exploring Strategic Alternatives
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Announces the Completion of $4.1 Million Private Placement
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Announces $4.1 Million Private Placement
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore Excipients
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences to Participate in Four Upcoming Conferences
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences to Present at 22nd Annual PepTalk Conference
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Appoints Janice Marie McCourt as Chief Business Officer
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Expands Woburn Operations
From Comera Life Sciences
Via GlobeNewswire
Comera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore Platform
From Comera Life Sciences Holdings, Inc.
Via Business Wire
Comera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial Officer
From Comera Life Sciences Holdings, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.